The global market for cancer-focused genetic testing services is on a transformative growth trajectory, with projections estimating a market size of USD 8,472.70 million by 2024, and an expected ...

Six/UW/Seattle Children’s Cancer Consortium scientists received new funding from the Breast Cancer Research Foundation to ...

Six/UW/Seattle Children’s Cancer Consortium scientists received new funding from the Breast Cancer Research Foundation to ...

Lytic induction therapy has been developed to selectively kill EBV-positive cancer cells by triggering viral reactivation ...

The Albany Fire Department is addressing a critical yet often-overlooked health risk for its firefighters by offering specialized screenings for esophageal cancer.

We will use optical genome mapping for molecular diagnosis of brain tumors, which is a new application of this technology specifically designed to detect structural variants, meaning large changes ...

Comprehensive Genomic Profiling (CGP) is reshaping cancer treatment by enabling precision oncology at an unprecedented scale.

Ann & Robert H. Lurie Children’s Hospital of Chicago was awarded $3.7 million through the National Cancer Institute Cancer Moonshot Scholars program to advance precision diagnosis of brain tumors in ...

Syantra, Inc., a privately held, precision biotechnology company, announced it has filed an international patent application for its pioneering platform for the early detection of cancer and other ...

Cancer cells can evade the immune system, create their own blood supply, and adapt to survive under different conditions.

Pangea Laboratory has partnered with Unilabs, a leading European provider of clinical laboratory testing and diagnostic ...

biomodal, an omics-based life sciences technology and analytics company, today announced it will present new data highlighting the utility of duet mul ...